3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Thyroid Nodule
2
Pain
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Agnosia
2
Prostatic Neoplasms
1
Neuroma
1
Neuralgia
1
Neoplasm Metastasis
1
Myoma
1
Multiple Pulmonary Nodules
1
Multiple Advanced Tumors After PD-1 Therapy Failure
1
Menorrhagia
1
Lymphoma, Follicular
1
Lipoma
1
Leiomyoma
1
Hypesthesia
1
Hyperthyroidism
1
Hyperaldosteronism
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cicatrix
1
Carcinoma, Renal Cell
1
Breast Cancer Female
1
Bone Cancer Metastatic
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Adenocarcinoma
1
ACTH Syndrome, Ectopic
1
Interventions
Letrozole
2
Bupivacaine
2
pyrotinib
1
exemestane
1
abemaciclib
1
Tumor Burden
1
Thioctic Acid
1
Tamoxifen
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sodium Chloride
1
Ropivacaine
1
Radiotherapy
1
Radiofrequency Ablation
1
Mastectomy, Segmental
1
Mastectomy
1
Mammaplasty
1
Drug Therapy
1
Dexmedetomidine
1
Control Groups
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Cancer Female
×
Radiofrequency Ablation
×
1 year
×
Clear all
NCT04389216
2025-09-15
RFA
Hospital Universitari de Bellvitge
Phase NA
Completed
30 enrolled